Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

New Insights into HIV/AIDS-Associated Cryptococcosis.

Antinori S.

ISRN AIDS. 2013 Feb 25;2013:471363. doi: 10.1155/2013/471363. Review.

2.

[Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].

Muyembe Tamfum JJ, Mupapa Kibadi D, Nganda L, Ngwala-Bikindu D, Kuezina T, Kela-We I, Vandepitte J.

Med Trop (Mars). 1992 Oct-Dec;52(4):435-8. Review. French.

PMID:
1494313
3.

Molecular diagnosis of cryptococcal meningitis in cerebrospinal fluid: comparison of primer sets for Cryptococcus neoformans and Cryptococcus gattii species complex.

Martins Mdos A, Brighente KB, Matos TA, Vidal JE, Hipólito DD, Pereira-Chioccola VL.

Braz J Infect Dis. 2015 Jan-Feb;19(1):62-7. doi: 10.1016/j.bjid.2014.09.004. Epub 2014 Dec 16.

4.

Symptomatic relapse of HIV-associated cryptococcal meningitis: recurrent cryptococcal meningitis or Cryptococcus-related immune reconstitution inflammatory syndrome?

Jhamb R, Kashyap B, Das S, Berry N, Garg A.

Int J STD AIDS. 2014 Apr;25(5):369-72. doi: 10.1177/0956462413506889. Epub 2013 Oct 9.

PMID:
24108453
5.

Cryptococcus tetragattii as a major cause of cryptococcal meningitis among HIV-infected individuals in Harare, Zimbabwe.

Nyazika TK, Hagen F, Meis JF, Robertson VJ.

J Infect. 2016 Jun;72(6):745-752. doi: 10.1016/j.jinf.2016.02.018. Epub 2016 Mar 30.

PMID:
27038502
6.

Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.

McKenney J, Bauman S, Neary B, Detels R, French A, Margolick J, Doherty B, Klausner JD.

Clin Infect Dis. 2015 Mar 15;60(6):959-65. doi: 10.1093/cid/ciu937. Epub 2014 Nov 24.

7.

Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution.

Katchanov J, Branding G, Jefferys L, Arastéh K, Stocker H, Siebert E.

Int J STD AIDS. 2016 Feb;27(2):110-7. doi: 10.1177/0956462415574633. Epub 2015 Feb 18.

PMID:
25693580
8.

A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.

Chau TT, Mai NH, Phu NH, Nghia HD, Chuong LV, Sinh DX, Duong VA, Diep PT, Campbell JI, Baker S, Hien TT, Lalloo DG, Farrar JJ, Day JN.

BMC Infect Dis. 2010 Jul 9;10:199. doi: 10.1186/1471-2334-10-199.

9.

Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.

French N, Gray K, Watera C, Nakiyingi J, Lugada E, Moore M, Lalloo D, Whitworth JA, Gilks CF.

AIDS. 2002 May 3;16(7):1031-8.

PMID:
11953469
10.

In-hospital mortality of HIV-infected cryptococcal meningitis patients with C. gattii and C. neoformans infection in Gaborone, Botswana.

Steele KT, Thakur R, Nthobatsang R, Steenhoff AP, Bisson GP.

Med Mycol. 2010 Dec;48(8):1112-5. doi: 10.3109/13693781003774689. Epub 2010 May 3.

PMID:
20438294
11.

Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis.

Wiesner DL, Moskalenko O, Corcoran JM, McDonald T, Rolfes MA, Meya DB, Kajumbula H, Kambugu A, Bohjanen PR, Knight JF, Boulware DR, Nielsen K.

MBio. 2012 Sep 25;3(5). pii: e00196-12. doi: 10.1128/mBio.00196-12. Print 2012.

12.

Preventing deaths from cryptococcal meningitis: from bench to bedside.

Roy M, Chiller T.

Expert Rev Anti Infect Ther. 2011 Sep;9(9):715-7. doi: 10.1586/eri.11.86. Review.

PMID:
21905781
13.

Cryptococcus neoformans population diversity and clinical outcomes of HIV-associated cryptococcal meningitis patients in Zimbabwe.

Nyazika TK, Hagen F, Machiridza T, Kutepa M, Masanganise F, Hendrickx M, Boekhout T, Magombei-Majinjiwa T, Siziba N, Chin'ombe N, Mateveke K, Meis JF, Robertson VJ.

J Med Microbiol. 2016 Nov;65(11):1281-1288. doi: 10.1099/jmm.0.000354. Epub 2016 Sep 13.

PMID:
27638836
14.

Epidemiology and management of cryptococcal meningitis: developments and challenges.

Pukkila-Worley R, Mylonakis E.

Expert Opin Pharmacother. 2008 Mar;9(4):551-60. doi: 10.1517/14656566.9.4.551. Review.

PMID:
18312157
16.

Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.

Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A, Harrison TS.

Nat Rev Neurol. 2017 Jan;13(1):13-24. doi: 10.1038/nrneurol.2016.167. Epub 2016 Nov 25. Review.

PMID:
27886201
17.

Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.

Kangogo M, Bader O, Boga H, Wanyoike W, Folba C, Worasilchai N, Weig M, Groß U, Bii CC.

Mycoses. 2015 Nov;58(11):665-70. doi: 10.1111/myc.12411. Epub 2015 Sep 25.

PMID:
26404188
18.

Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS.

Davis JA, Horn DL, Marr KA, Fishman JA.

Transpl Infect Dis. 2009 Oct;11(5):432-7. doi: 10.1111/j.1399-3062.2009.00424.x. Epub 2009 Jul 22.

PMID:
19638005
19.

Cryptococcal infections: changing epidemiology and implications for therapy.

La Hoz RM, Pappas PG.

Drugs. 2013 May;73(6):495-504. doi: 10.1007/s40265-013-0037-z. Review.

PMID:
23575940
20.

A paradoxical decline: intracranial lesions in two HIV-positive patients recovering from cryptococcal meningitis.

Pettersen KD, Pappas PG, Chin-Hong P, Baxi SM.

BMJ Case Rep. 2015 Oct 16;2015. pii: bcr2015212108. doi: 10.1136/bcr-2015-212108.

PMID:
26475880

Supplemental Content

Support Center